175 related articles for article (PubMed ID: 1380989)
1. Treatment of recurrent gliomas with eflornithine.
Levin VA; Prados MD; Yung WK; Gleason MJ; Ictech S; Malec M
J Natl Cancer Inst; 1992 Sep; 84(18):1432-7. PubMed ID: 1380989
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.
Levin VA; Chamberlain MC; Prados MD; Choucair AK; Berger MS; Silver P; Seager M; Gutin PH; Davis RL; Wilson CB
Cancer Treat Rep; 1987 May; 71(5):459-64. PubMed ID: 3105881
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma.
Buckner JC; Burch PA; Cascino TL; O'Fallon JR; Scheithauer BW
J Neurooncol; 1998 Jan; 36(1):65-70. PubMed ID: 9525827
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.
Prados M; Rodriguez L; Chamberlain M; Silver P; Levin V
Neurosurgery; 1989 Jun; 24(6):806-9. PubMed ID: 2546093
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas.
Levin VA; Ictech SE; Hess KR
CNS Oncol; 2018 Apr; 7(2):CNS16. PubMed ID: 29378419
[TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.
Levin VA; Prados MD
J Clin Oncol; 1992 May; 10(5):766-71. PubMed ID: 1314890
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
[TBL] [Abstract][Full Text] [Related]
11. A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
Pipas JM; Meyer LP; Rhodes CH; Cromwell LD; McDonnell CE; Kingman LS; Rigas JR; Fadul CE
J Neurooncol; 2005 Feb; 71(3):301-5. PubMed ID: 15735921
[TBL] [Abstract][Full Text] [Related]
12. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
15. Response and progression in recurrent malignant glioma.
Hess KR; Wong ET; Jaeckle KA; Kyritsis AP; Levin VA; Prados MD; Yung WK
Neuro Oncol; 1999 Oct; 1(4):282-8. PubMed ID: 11550320
[TBL] [Abstract][Full Text] [Related]
16. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
Clarke K; Basser RL; Underhill C; Mitchell P; Bartlett J; Cher L; Findlay M; Dalley D; Pell M; Byrne M; Geldard H; Hill JS; Maher D; Fox RM; Green MD; Kaye AH
J Clin Oncol; 1999 Aug; 17(8):2579-84. PubMed ID: 10561325
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Fulton D; Urtasun R; Forsyth P
J Neurooncol; 1996 Feb; 27(2):149-55. PubMed ID: 8699237
[TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.
Yung WK; Prados M; Levin VA; Fetell MR; Bennett J; Mahaley MS; Salcman M; Etcubanas E
J Clin Oncol; 1991 Nov; 9(11):1945-9. PubMed ID: 1658242
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme.
Rosenthal MA; Gruber ML; Glass J; Nirenberg A; Finlay J; Hochster H; Muggia FM
J Neurooncol; 2000 Mar; 47(1):59-63. PubMed ID: 10930101
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors.
Rodriguez LA; Prados M; Silver P; Levin VA
Cancer; 1989 Dec; 64(12):2420-3. PubMed ID: 2555038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]